Skip to main content
Clinical Trials/CTRI/2015/10/006323
CTRI/2015/10/006323Completed未知

TO STUDY THE EFFECT OF KANTAKARYAVALEHYA ON IgE LEVELS IN CHILDHOOD ASTHMA

RGUHS0 sites20 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Patients in the age group of 5 to 15 years.
  • 3.Increased IgE levels
  • 4.Intermittent, Mild Persistent and Moderate Persistent Asthma.

Exclusion Criteria

  • 1.Patients with Cardiovascular, Renal and other systemic disorders.
  • 2.Patients with other chronic and infective disorders of respiratory system.
  • 3.Primary Complex.
  • 4.Foreign body aspiration.
  • 5.Acute Severe Asthma.
  • 6.Severe Persistent Asthma

Investigators

Sponsor
RGUHS

Similar Trials